Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

FHS
June 27, 2024
4:47 am

Combining exercise with GLP-1 RA liraglutide results in significant weight loss while preserving bone health in adults with obesity.

Neumora’s big neuroscience plans head toward the Nasdaq in second PhIII biotech IPO pitch in 24 hours

The largely dormant biotech IPO market started sizzling Friday, with two Phase III drug developers sending in their pitches for Nasdaq debuts this fall. After

August 26, 2023

New food-grade natural solution created for tackling obesity

As obesity rates continue to rise, many are turning to prescription medicines like Ozempic for weight loss. But with significant side effects, accessibility and cost issues, alternatives are

December 3, 2024

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors | Psychedelic Invest

NEW YORK and MELBOURNE, Australia, Sept. 10, 2024 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), (the “Company” or “Incannex”), a clinical-stage biopharmaceutical company developing life-changing

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.